We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,122 hedge funds and large institutions have $60B invested in Biogen in 2017 Q4 according to their latest regulatory filings, with 167 funds opening new positions, 399 increasing their positions, 384 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

248% more first-time investments, than exits

New positions opened: 167 | Existing positions closed: 48

11% more funds holding

Funds holding: 1,014 → 1,122 (+108)

4% more repeat investments, than reductions

Existing positions increased: 399 | Existing positions reduced: 384

2% more capital invested

Capital invested by funds: $59B → $60B (+$967M)

0.05% less ownership

Funds ownership: 89.15% → 89.1% (-0.05%)

26% less funds holding in top 10

Funds holding in top 10: 38 → 28 (-10)

32% less call options, than puts

Call options by funds: $989M | Put options by funds: $1.44B

Holders
1,122
Holders Change
+108
Holders Change %
+10.65%
% of All Funds
25.45%
Holding in Top 10
28
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-26.32%
% of All Funds
0.64%
New
167
Increased
399
Reduced
384
Closed
48
Calls
$989M
Puts
$1.44B
Net Calls
-$456M
Net Calls Change
-$187M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$623M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$233M
3
PC
PointState Capital
New York
+$158M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$124M
5
JP Morgan Chase
JP Morgan Chase
New York
+$107M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$689M
2
TCIM
TIAA CREF Investment Management
New York
-$232M
3
Citadel Advisors
Citadel Advisors
Florida
-$161M
4
Bank of America
Bank of America
North Carolina
-$156M
5
O
OrbiMed
New York
-$128M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWP
476
Stratos Wealth Partners
Ohio
$2.88M +$52.3K +163 +2%
MM
477
Meridian Management
Arkansas
$2.88M -$70.6K -220 -2%
ECM
478
Estabrook Capital Management
New York
$2.87M – – –
Victory Capital Management
479
Victory Capital Management
Texas
$2.84M +$151K +470 +6%
SCM
480
Stevens Capital Management
Pennsylvania
$2.78M -$1.58M -4,911 -36%
AMI
481
Amica Mutual Insurance
Rhode Island
$2.72M -$900K -2,804 -25%
LWCFA
482
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$2.71M – – –
AIIMS
483
Analyst IMS Investment Management Services
Israel
$2.69M -$72.5K -226 -3%
LMGAM
484
Liberty Mutual Group Asset Management
Massachusetts
$2.69M -$139K -433 -5%
HP
485
HealthInvest Partners
Sweden
$2.68M -$3.85M -12,000 -59%
AssetMark Inc
486
AssetMark Inc
California
$2.66M +$2.55M +7,948 +2,043%
ECM
487
ETrade Capital Management
Virginia
$2.65M +$101K +314 +4%
APFBOT
488
Amica Pension Fund Board of Trustees
Rhode Island
$2.64M – – –
SAM
489
Stansberry Asset Management
Texas
$2.62M +$2.63M +8,212 New
SRAM
490
Stone Ridge Asset Management
New York
$2.61M +$2.63M +8,200 New
TMAM
491
Tokio Marine Asset Management
Japan
$2.61M -$145K -453 -5%
OTPPB
492
Ontario Teachers' Pension Plan Board
Ontario, Canada
$2.61M +$570K +1,778 +28%
FMT
493
First Mercantile Trust
Tennessee
$2.54M -$483K -1,506 -16%
BP
494
Broadleaf Partners
Ohio
$2.54M +$2.55M +7,964 New
Brown Advisory
495
Brown Advisory
Maryland
$2.53M +$48.8K +152 +2%
Daiwa Securities Group
496
Daiwa Securities Group
Japan
$2.53M +$46.2K +144 +2%
W
497
Wealthfront
California
$2.52M +$645K +2,011 +34%
MWAC
498
Mariner Wealth Advisors (Cincinnati)
Ohio
$2.47M +$59.3K +185 +2%
LNB
499
Ledyard National Bank
$2.46M -$84.1K -262 -3%
PS
500
Pensionfund Sabic
Netherlands
$2.45M – – –
18 19
20
21 22

BIIB Hedge Fund Activity: Q4 2017 in Review

1,122 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q4 2017, worth a combined $60B — up 1.6% from $59B a quarter earlier.

Buyers outnumbered sellers: 167 funds opened new BIIB positions and 48 closed out — a net gain of 119 holders — while 399 added to existing stakes and 384 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $623M. The largest seller was T. Rowe Price Associates, cutting an estimated $689M.

  • 1,122 institutional investors held Biogen (BIIB) as of Q4 2017, up from 1,014 in Q3 2017.
  • Funds reported $60B of Biogen stock for Q4 2017, up 1.6% quarter-over-quarter.
  • 167 funds opened new Biogen positions in Q4 2017 and 48 closed out, a net change of +119 holders.
  • The largest Biogen buyer in Q4 2017 was Fidelity Investments, an estimated $623M added.
  • The largest Biogen seller in Q4 2017 was T. Rowe Price Associates, an estimated $689M sold.

Based on aggregated 13F filings for Q4 2017.